Windmill Cardiovascular Systems, Inc. focuses on innovative technologies aimed at improving cardiovascular health. The company is dedicated to developing advanced medical devices that enhance the diagnosis and treatment of cardiovascular diseases. Their product pipeline includes cutting-edge solutions designed to address various cardiovascular conditions, emphasizing minimally invasive techniques that aim to improve patient outcomes and reduce recovery times.

The technologies employed by Windmill Cardiovascular Systems are rooted in a deep understanding of cardiovascular physiology and engineering principles. Their approach integrates sophisticated imaging and monitoring systems, which allow for real-time assessment of cardiovascular function. Additionally, the company is committed to leveraging data analytics and machine learning to refine their devices and improve clinical decision-making, ultimately striving to provide safer and more effective treatment options for patients with cardiovascular issues.

United States

Windmill Cardiovascular Systems has developed a new pumping paradigm to deliver synchronous, pulsatile, low-shear flow to support patients
with end-stage heart failure. The Toroidal Ventricular Assist Device (TORVAD) has the potential to reduce the high adverse event rates associated with
current VADs, which could improve the survival and quality of life for patients.

Windmill Cardiovascular Systems, Inc.

Company Details